Table 2.
Index | Formula | Compounds | m/z | Ion mode | VIP | P value | Log2FC |
---|---|---|---|---|---|---|---|
LIPID-P-0016 | C19H37NO5 | 3-Hydroxy-dodecanoyl-carnitine | 360.2760 | [M + H]+ | 1.8079 | 0.0759 | −4.1566 |
LIPID-P-0027 | C15H27NO4 | Octenoyl-carnitine | 286.2025 | [M + H]+ | 1.2305 | 0.1029 | −1.1566 |
LIPID-P-0715 | C48H80NO10P | PS(22 : 2/20 : 5) | 862.5598 | [M + H]+ | 1.6372 | 0.0003 | −1.4132 |
LIPID-P-0840 | C51H94O6 | TG(14 : 0/16 : 1/18 : 1) | 820.7394 | [M + NH4]+ | 1.0090 | 0.0975 | −1.0180 |
LIPID-P-0898 | C51H92O6 | TG(14 : 1/16 : 1/18 : 1) | 818.7237 | [M + NH4]+ | 1.1005 | 0.1046 | −1.3527 |
LIPID-P-0900 | C51H92O6 | TG(14 : 0/16 : 1/18 : 2) | 818.7237 | [M + NH4]+ | 1.3069 | 0.0637 | −1.0904 |
LIPID-P-0974 | C51H90O6 | TG(14 : 1/14 : 1/20 : 2) | 816.7081 | [M + NH4]+ | 1.2559 | 0.0663 | −1.2510 |
LIPID-P-0976 | C51H90O6 | TG(14 : 0/16 : 1/18 : 3) | 816.7081 | [M + NH4]+ | 1.3677 | 0.0625 | −1.2017 |
LIPID-P-1032 | C53H92O6 | TG(16 : 0/16 : 1/18 : 4) | 842.7237 | [M + NH4]+ | 1.2610 | 0.0762 | −1.2353 |
LIPID-P-1036 | C53H92O6 | TG(14 : 0/18 : 2/18 : 3) | 842.7237 | [M + NH4]+ | 1.5812 | 0.0190 | −1.0030 |
LIPID-P-1081 | C53H90O6 | TG(14 : 0/18 : 3/18 : 3) | 840.7081 | [M + NH4]+ | 1.5392 | 0.0118 | −1.0117 |
LIPID-P-1122 | C55H92O6 | TG(14 : 0/18 : 4/20 : 3) | 866.7237 | [M + NH4]+ | 1.6973 | 0.0061 | −1.0558 |
LIPID-P-1123 | C55H92O6 | TG(16 : 1/16 : 1/20 : 5) | 866.7237 | [M + NH4]+ | 1.6026 | 0.0093 | −1.2570 |
LIPID-P-1155 | C57H94O6 | TG(14 : 0/20 : 3/20 : 5) | 892.7394 | [M + NH4]+ | 1.5143 | 0.0247 | −1.0425 |
LIPID-P-1176 | C57H92O6 | TG(18 : 1/18 : 4/18 : 4) | 890.7237 | [M + NH4]+ | 1.6034 | 0.0224 | −1.3360 |
LIPID-P-1190 | C57H90O6 | TG(18 : 2/18 : 4/18 : 4) | 888.7081 | [M + NH4]+ | 1.5834 | 0.0152 | −1.0594 |